WILLIAMS RONALD A 4

What Happened

• Ronald A. Williams, a director of agilon health, was granted 2,133 restricted stock units (RSUs) on June 2, 2026. The grant was reported at $0.00 per share (total reported value $0) because these are equity awards, not a cash purchase or sale.

Key Details

• Transaction date: June 2, 2026. Report filed: June 4, 2026 (timely).
• Grant type/code: Award/Grant (A). Shares granted: 2,133 RSUs. Price per share reported: $0.00; total reported value: $0.
• Vesting: RSUs vest in full on June 2, 2027, subject to continued service as a director (footnote F1).
• Shares owned after transaction: not specified in the provided excerpt; filing notes that reported ownership figures reflect a 1-for-25 reverse stock split effective March 30, 2026 (footnote F2).
• Footnote F3 indicates the beneficial ownership count includes restricted stock units.

Context

• RSU grants are a form of compensation rather than an open-market purchase or sale. They do not represent an immediate cash outlay by the insider and typically vest over time if service conditions are met. The reverse split note means reported share counts are post-split and smaller than pre-split amounts.